Իրական պոլիցիտեմիա (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Իրական պոլիցիտեմիա" in Armenian language version.

refsWebsite

Global rank Armenian rank

27nih.gov

4^th place

3^rd place

18doi.org

2^nd place

4^th place

8semanticscholar.org

11^th place

428^th place

5archive.org

6^th place

3hematologyandoncology.net

low place

1britannica.com

40^th place

20^th place

1mayoclinic.com

3,634^th place

498^th place

1medscape.com

719^th place

149^th place

1mayoclinic.org

1,610^th place

530^th place

1europa.eu

68^th place

88^th place

1fda.gov

447^th place

244^th place

1businesswire.com

615^th place

1,236^th place

archive.org

Steinman H, Kobza-Black A, Lotti T, Brunetti L, Panconesi E, Greaves M (1987). «Polycythaemia rubra vera and water-induced pruritus: blood histamine levels and cutaneous fibrinolytic activity before and after water challenge». Br J Dermatol. 116 (3): 329–33. doi:10.1111/j.1365-2133.1987.tb05846.x. PMID 3567071. S2CID 22068469.
Jackson N, Burt D, Crocker J, Boughton B (1987). «Skin mast cells in polycythaemia vera: relationship to the pathogenesis and treatment of pruritus». Br J Dermatol. 116 (1): 21–9. doi:10.1111/j.1365-2133.1987.tb05787.x. PMID 3814512. S2CID 38261640.
Torgano G, Mandelli C, Massaro P, Abbiati C, Ponzetto A, Bertinieri G, Bogetto S, Terruzzi E, de Franchis R (2002). «Gastroduodenal lesions in polycythaemia vera: frequency and role of Helicobacter pylori». Br J Haematol. 117 (1): 198–202. doi:10.1046/j.1365-2141.2002.03380.x. PMID 11918555.
van Genderen P, Michiels J (1997). «Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera». Semin Thromb Hemost. 23 (4): 357–63. doi:10.1055/s-2007-996109. PMID 9263352.
Michiels J (1997). «Erythromelalgia and vascular complications in polycythemia vera». Semin Thromb Hemost. 23 (5): 441–54. doi:10.1055/s-2007-996121. PMID 9387203.

britannica.com

«Polycythemia vera | pathology | Britannica». www.britannica.com (անգլերեն). Վերցված է 2023 թ․ օգոստոսի 2-ին.

businesswire.com

«U.S. FDA Approves Besremi (ropeginterferon alfa-2b-njft) as the Only Interferon for Adults With Polycythemia Vera» (Press release). PharmaEssentia. 2021 թ․ նոյեմբերի 12. Վերցված է 2021 թ․ նոյեմբերի 14-ին – via Business Wire.

doi.org

Saini KS, Patnaik MM, Tefferi A (2010). «Polycythemia vera-associated pruritus and its management». Eur J Clin Invest. 40 (9): 828–34. doi:10.1111/j.1365-2362.2010.02334.x. PMID 20597963. S2CID 13638890.
Steinman H, Kobza-Black A, Lotti T, Brunetti L, Panconesi E, Greaves M (1987). «Polycythaemia rubra vera and water-induced pruritus: blood histamine levels and cutaneous fibrinolytic activity before and after water challenge». Br J Dermatol. 116 (3): 329–33. doi:10.1111/j.1365-2133.1987.tb05846.x. PMID 3567071. S2CID 22068469.
Jackson N, Burt D, Crocker J, Boughton B (1987). «Skin mast cells in polycythaemia vera: relationship to the pathogenesis and treatment of pruritus». Br J Dermatol. 116 (1): 21–9. doi:10.1111/j.1365-2133.1987.tb05787.x. PMID 3814512. S2CID 38261640.
Fjellner B, Hägermark O (1979). «Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement». Acta Derm Venereol. 59 (6): 505–12. doi:10.2340/0001555559505512 (inactive 2022 թ․ դեկտեմբերի 31). PMID 94209. S2CID 6909368.{{cite journal}}: CS1 սպաս․ DOI inactive as of 2022 (link)
Torgano G, Mandelli C, Massaro P, Abbiati C, Ponzetto A, Bertinieri G, Bogetto S, Terruzzi E, de Franchis R (2002). «Gastroduodenal lesions in polycythaemia vera: frequency and role of Helicobacter pylori». Br J Haematol. 117 (1): 198–202. doi:10.1046/j.1365-2141.2002.03380.x. PMID 11918555.
van Genderen P, Michiels J (1997). «Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera». Semin Thromb Hemost. 23 (4): 357–63. doi:10.1055/s-2007-996109. PMID 9263352.
Michiels J (1997). «Erythromelalgia and vascular complications in polycythemia vera». Semin Thromb Hemost. 23 (5): 441–54. doi:10.1055/s-2007-996121. PMID 9387203.
Landolfi R, Ciabattoni G, Patrignani P, Castellana M, Pogliani E, Bizzi B, Patrono C (1992). «Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo». Blood. 80 (8): 1965–71. doi:10.1182/blood.V80.8.1965.1965. PMID 1327286.
«The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia». Blood. 127 (20): 2391–2405. 2016. doi:10.1182/blood-2016-03-643544. PMID 27069254. {{cite journal}}: Cite uses deprecated parameter |authors= (օգնություն)
Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR (2005). «Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders». Lancet. 365 (9464): 1054–61. doi:10.1016/S0140-6736(05)71142-9. PMID 15781101. S2CID 24419497.
Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ, Boggon TJ, Wlodarska I, Clark JJ, Moore S, Adelsperger J, Koo S, Lee JC, Gabriel S, Mercher T, D'Andrea A, Frohling S, Dohner K, Marynen P, Vandenberghe P, Mesa RA, Tefferi A, Griffin JD, Eck MJ, Sellers WR, Meyerson M, Golub TR, Lee SJ, Gilliland DG (2005). «Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis». Cancer Cell. 7 (4): 387–97. doi:10.1016/j.ccr.2005.03.023. PMID 15837627.
Thurmes PJ, Steensma DP (2006 թ․ հուլիս). «Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis». Eur. J. Haematol. 77 (1): 57–60. doi:10.1111/j.1600-0609.2006.00667.x. PMID 16827884. S2CID 37383942.
Streiff MB, Smith B, Spivak JL (2002). «The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns». Blood. 99 (4): 1144–9. doi:10.1182/blood.V99.4.1144. PMID 11830459.
Di Pollina L, Mulligan R, Juillerat Van der Linden A, Michel JP, Gold G (2000). «Cognitive impairment in polycythemia vera: partial reversibility upon lowering of the hematocrit». Eur. Neurol. 44 (1): 57–9. doi:10.1159/000008194. PMID 10894997. S2CID 40928145.
Björkholm, M; Derolf, AR; Hultcrantz, M; և այլք: (2011 թ․ հունիսի 10). «Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms». Journal of Clinical Oncology. 29 (17): 2410–5. doi:10.1200/JCO.2011.34.7542. PMC 3107755. PMID 21537037.
Li Z, Xu M, Xing S, Ho W, Ishii T, Li Q, Fu X, Zhao Z (2007). «Erlotinib Effectively Inhibits JAK2V617F Activity and Polycythemia Vera Cell Growth». J Biol Chem. 282 (6): 3428–32. doi:10.1074/jbc.C600277200. PMC 2096634. PMID 17178722.
Tefferi, A; Vannucchi, AM; Barbui, T (2018 թ․ հունվարի 10). «Polycythemia vera treatment algorithm 2018». Blood Cancer Journal. 8 (1): 3. doi:10.1038/s41408-017-0042-7. PMC 5802495. PMID 29321547.
Anía B, Suman V, Sobell J, Codd M, Silverstein M, Melton L (1994). «Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989». Am J Hematol. 47 (2): 89–93. doi:10.1002/ajh.2830470205. PMID 8092146. S2CID 31536624.

europa.eu

ema.europa.eu

«Besremi EPAR». European Medicines Agency (EMA). 2018 թ․ դեկտեմբերի 12. Վերցված է 2021 թ․ նոյեմբերի 14-ին.

fda.gov

«FDA Approves Treatment for Rare Blood Disease». U.S. Food and Drug Administration (FDA) (Press release). 2021 թ․ նոյեմբերի 12. Վերցված է 2021 թ․ նոյեմբերի 12-ին. This article incorporates text from this source, which is in the public domain.

hematologyandoncology.net

«Highlights in polycythemia vera from the 2016 EHA congress». Clin Adv Hematol Oncol. 14 (10): 810–813. 2016. PMID 27930632. {{cite journal}}: Cite uses deprecated parameter |authors= (օգնություն)
«Highlights in polycythemia vera from the 2016 EHA congress». Clin Adv Hematol Oncol. 14 (10): 810–813. 2016. PMID 27930632. {{cite journal}}: Cite uses deprecated parameter |authors= (օգնություն)
«Highlights in polycythemia vera from the 2016 EHA congress». Clin Adv Hematol Oncol. 14 (10): 810–813. 2016. PMID 27930632. {{cite journal}}: Cite uses deprecated parameter |authors= (օգնություն)

mayoclinic.com

Mayo Clinic staff. «Polycythemia vera - MayoClinic.com». Polycythemia vera: Definition. Mayo Clinic. Վերցված է 2011 թ․ սեպտեմբերի 3-ին.

mayoclinic.org

«Polycythemia vera - Diagnosis and treatment - Mayo Clinic». www.mayoclinic.org (անգլերեն). Վերցված է 2022 թ․ մարտի 11-ին.

medscape.com

emedicine.medscape.com

«Polycythemia Vera Follow-up». Վերցված է 2011 թ․ սեպտեմբերի 3-ին.

nih.gov

pubmed.ncbi.nlm.nih.gov

Saini KS, Patnaik MM, Tefferi A (2010). «Polycythemia vera-associated pruritus and its management». Eur J Clin Invest. 40 (9): 828–34. doi:10.1111/j.1365-2362.2010.02334.x. PMID 20597963. S2CID 13638890.
Steinman H, Kobza-Black A, Lotti T, Brunetti L, Panconesi E, Greaves M (1987). «Polycythaemia rubra vera and water-induced pruritus: blood histamine levels and cutaneous fibrinolytic activity before and after water challenge». Br J Dermatol. 116 (3): 329–33. doi:10.1111/j.1365-2133.1987.tb05846.x. PMID 3567071. S2CID 22068469.
Jackson N, Burt D, Crocker J, Boughton B (1987). «Skin mast cells in polycythaemia vera: relationship to the pathogenesis and treatment of pruritus». Br J Dermatol. 116 (1): 21–9. doi:10.1111/j.1365-2133.1987.tb05787.x. PMID 3814512. S2CID 38261640.
Fjellner B, Hägermark O (1979). «Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement». Acta Derm Venereol. 59 (6): 505–12. doi:10.2340/0001555559505512 (inactive 2022 թ․ դեկտեմբերի 31). PMID 94209. S2CID 6909368.{{cite journal}}: CS1 սպաս․ DOI inactive as of 2022 (link)
Berlin NI (1975). «Diagnosis and classification of polycythemias». Semin Hematol. 12 (4): 339–51. PMID 1198126.
Torgano G, Mandelli C, Massaro P, Abbiati C, Ponzetto A, Bertinieri G, Bogetto S, Terruzzi E, de Franchis R (2002). «Gastroduodenal lesions in polycythaemia vera: frequency and role of Helicobacter pylori». Br J Haematol. 117 (1): 198–202. doi:10.1046/j.1365-2141.2002.03380.x. PMID 11918555.
van Genderen P, Michiels J (1997). «Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera». Semin Thromb Hemost. 23 (4): 357–63. doi:10.1055/s-2007-996109. PMID 9263352.
Michiels J (1997). «Erythromelalgia and vascular complications in polycythemia vera». Semin Thromb Hemost. 23 (5): 441–54. doi:10.1055/s-2007-996121. PMID 9387203.
Landolfi R, Ciabattoni G, Patrignani P, Castellana M, Pogliani E, Bizzi B, Patrono C (1992). «Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo». Blood. 80 (8): 1965–71. doi:10.1182/blood.V80.8.1965.1965. PMID 1327286.
«The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia». Blood. 127 (20): 2391–2405. 2016. doi:10.1182/blood-2016-03-643544. PMID 27069254. {{cite journal}}: Cite uses deprecated parameter |authors= (օգնություն)
«Highlights in polycythemia vera from the 2016 EHA congress». Clin Adv Hematol Oncol. 14 (10): 810–813. 2016. PMID 27930632. {{cite journal}}: Cite uses deprecated parameter |authors= (օգնություն)
Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR (2005). «Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders». Lancet. 365 (9464): 1054–61. doi:10.1016/S0140-6736(05)71142-9. PMID 15781101. S2CID 24419497.
Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ, Boggon TJ, Wlodarska I, Clark JJ, Moore S, Adelsperger J, Koo S, Lee JC, Gabriel S, Mercher T, D'Andrea A, Frohling S, Dohner K, Marynen P, Vandenberghe P, Mesa RA, Tefferi A, Griffin JD, Eck MJ, Sellers WR, Meyerson M, Golub TR, Lee SJ, Gilliland DG (2005). «Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis». Cancer Cell. 7 (4): 387–97. doi:10.1016/j.ccr.2005.03.023. PMID 15837627.
«Highlights in polycythemia vera from the 2016 EHA congress». Clin Adv Hematol Oncol. 14 (10): 810–813. 2016. PMID 27930632. {{cite journal}}: Cite uses deprecated parameter |authors= (օգնություն)
Thurmes PJ, Steensma DP (2006 թ․ հուլիս). «Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis». Eur. J. Haematol. 77 (1): 57–60. doi:10.1111/j.1600-0609.2006.00667.x. PMID 16827884. S2CID 37383942.
«Highlights in polycythemia vera from the 2016 EHA congress». Clin Adv Hematol Oncol. 14 (10): 810–813. 2016. PMID 27930632. {{cite journal}}: Cite uses deprecated parameter |authors= (օգնություն)
Streiff MB, Smith B, Spivak JL (2002). «The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns». Blood. 99 (4): 1144–9. doi:10.1182/blood.V99.4.1144. PMID 11830459.
Di Pollina L, Mulligan R, Juillerat Van der Linden A, Michel JP, Gold G (2000). «Cognitive impairment in polycythemia vera: partial reversibility upon lowering of the hematocrit». Eur. Neurol. 44 (1): 57–9. doi:10.1159/000008194. PMID 10894997. S2CID 40928145.
Björkholm, M; Derolf, AR; Hultcrantz, M; և այլք: (2011 թ․ հունիսի 10). «Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms». Journal of Clinical Oncology. 29 (17): 2410–5. doi:10.1200/JCO.2011.34.7542. PMC 3107755. PMID 21537037.
Li Z, Xu M, Xing S, Ho W, Ishii T, Li Q, Fu X, Zhao Z (2007). «Erlotinib Effectively Inhibits JAK2V617F Activity and Polycythemia Vera Cell Growth». J Biol Chem. 282 (6): 3428–32. doi:10.1074/jbc.C600277200. PMC 2096634. PMID 17178722.
Tefferi, A; Vannucchi, AM; Barbui, T (2018 թ․ հունվարի 10). «Polycythemia vera treatment algorithm 2018». Blood Cancer Journal. 8 (1): 3. doi:10.1038/s41408-017-0042-7. PMC 5802495. PMID 29321547.
Passamonti F, Malabarba L, Orlandi E, Baratè C, Canevari A, Brusamolino E, Bonfichi M, Arcaini L, Caberlon S, Pascutto C, Lazzarino M (2003). «Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia». Haematologica. 88 (1): 13–8. PMID 12551821.
Anía B, Suman V, Sobell J, Codd M, Silverstein M, Melton L (1994). «Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989». Am J Hematol. 47 (2): 89–93. doi:10.1002/ajh.2830470205. PMID 8092146. S2CID 31536624.

ncbi.nlm.nih.gov

Björkholm, M; Derolf, AR; Hultcrantz, M; և այլք: (2011 թ․ հունիսի 10). «Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms». Journal of Clinical Oncology. 29 (17): 2410–5. doi:10.1200/JCO.2011.34.7542. PMC 3107755. PMID 21537037.
Li Z, Xu M, Xing S, Ho W, Ishii T, Li Q, Fu X, Zhao Z (2007). «Erlotinib Effectively Inhibits JAK2V617F Activity and Polycythemia Vera Cell Growth». J Biol Chem. 282 (6): 3428–32. doi:10.1074/jbc.C600277200. PMC 2096634. PMID 17178722.
Tefferi, A; Vannucchi, AM; Barbui, T (2018 թ․ հունվարի 10). «Polycythemia vera treatment algorithm 2018». Blood Cancer Journal. 8 (1): 3. doi:10.1038/s41408-017-0042-7. PMC 5802495. PMID 29321547.

nhlbi.nih.gov

«What Is Polycythemia Vera?». National Heart, Lung and Blood Institute. Վերցված է 2011 թ․ սեպտեմբերի 3-ին.

semanticscholar.org

api.semanticscholar.org

Saini KS, Patnaik MM, Tefferi A (2010). «Polycythemia vera-associated pruritus and its management». Eur J Clin Invest. 40 (9): 828–34. doi:10.1111/j.1365-2362.2010.02334.x. PMID 20597963. S2CID 13638890.
Steinman H, Kobza-Black A, Lotti T, Brunetti L, Panconesi E, Greaves M (1987). «Polycythaemia rubra vera and water-induced pruritus: blood histamine levels and cutaneous fibrinolytic activity before and after water challenge». Br J Dermatol. 116 (3): 329–33. doi:10.1111/j.1365-2133.1987.tb05846.x. PMID 3567071. S2CID 22068469.
Jackson N, Burt D, Crocker J, Boughton B (1987). «Skin mast cells in polycythaemia vera: relationship to the pathogenesis and treatment of pruritus». Br J Dermatol. 116 (1): 21–9. doi:10.1111/j.1365-2133.1987.tb05787.x. PMID 3814512. S2CID 38261640.
Fjellner B, Hägermark O (1979). «Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement». Acta Derm Venereol. 59 (6): 505–12. doi:10.2340/0001555559505512 (inactive 2022 թ․ դեկտեմբերի 31). PMID 94209. S2CID 6909368.{{cite journal}}: CS1 սպաս․ DOI inactive as of 2022 (link)
Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR (2005). «Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders». Lancet. 365 (9464): 1054–61. doi:10.1016/S0140-6736(05)71142-9. PMID 15781101. S2CID 24419497.
Thurmes PJ, Steensma DP (2006 թ․ հուլիս). «Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis». Eur. J. Haematol. 77 (1): 57–60. doi:10.1111/j.1600-0609.2006.00667.x. PMID 16827884. S2CID 37383942.
Di Pollina L, Mulligan R, Juillerat Van der Linden A, Michel JP, Gold G (2000). «Cognitive impairment in polycythemia vera: partial reversibility upon lowering of the hematocrit». Eur. Neurol. 44 (1): 57–9. doi:10.1159/000008194. PMID 10894997. S2CID 40928145.
Anía B, Suman V, Sobell J, Codd M, Silverstein M, Melton L (1994). «Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989». Am J Hematol. 47 (2): 89–93. doi:10.1002/ajh.2830470205. PMID 8092146. S2CID 31536624.